To the Editor We read with interest the recent article by Cheraghlou et al1 comparing overall survival among patients with stage I melanoma receiving Mohs micrographic surgery (MMS) or wide margin excision (WME). Although we agree that these data potentially support the use of MMS in patients with stage I tumors, we point out an erroneous use of the term noninferiority and suggest a significant limitation not mentioned.
Hopkins ZH, Secrest AM. Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research. JAMA Dermatol. 2020;156(9):1028–1029. doi:10.1001/jamadermatol.2020.1310
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.